Infiltration in Rheumatology With 3D Virtual Reality Headset Pilot Study for the Evaluation of Satisfaction (ICARE)
Icare
2 other identifiers
observational
30
1 country
1
Brief Summary
This study is to evaluate the satisfaction and feasibility according to the location of the use of a 3D virtual reality headset during an infiltration in rheumatology.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for all trials
Started May 2025
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
May 14, 2025
CompletedStudy Start
First participant enrolled
May 28, 2025
CompletedFirst Posted
Study publicly available on registry
August 5, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 1, 2026
CompletedStudy Completion
Last participant's last visit for all outcomes
May 1, 2026
CompletedAugust 5, 2025
July 1, 2025
11 months
May 14, 2025
July 28, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
To assess patient satisfaction with the use of 3D virtual reality with hypnotic induction during infiltration using Modified Client satisfaction score (CSQ-8)
Modified Client satisfaction score (CSQ-8) Minimum value: 0= not satisfied. Maximum value= 4 totally satisfied. Higher score mean better outcome.
day one
Secondary Outcomes (8)
To assess investigator satisfaction
Day one
To Modified Client satisfaction score (CSQ-8) score according to the location of the infiltration
Day one
Assess the patient's anxiety during infiltration using a numerical scale
day one
To Assess the patient's pain during the infiltration using a numerical scale.
day one
To Compare pain during infiltration to anticipated pain from infiltration using a numerical scale
day one
- +3 more secondary outcomes
Study Arms (1)
Infiltration
Patient requiring infiltration of the spine (high epidural or sacrococcygeal hiatus) of the subacromial-deltoid bursa or the knee
Eligibility Criteria
Patient requiring infiltration of the spine (high epidural or sacrococcygeal hiatus) of the subacromial-deltoid bursa or the knee
You may qualify if:
- years or older
- Patient requiring infiltration of the spine (high epidural or sacrococcygeal hiatus) of the subacromial-deltoid bursa or the knee, regardless of the product infiltrated
- Within the Rheumatology department of Saint-Antoine hospital (consultation or hospitalized)
You may not qualify if:
- History of severe psychiatric disorders - History of epilepsy
- Cognitive disorders
- Language barrier - Hearing aid-assisted deafness and/or ophthalmological problems leading to a major loss of vision (advanced cataract, visual impairment)
- Infiltration of the spine (high epidural or sacrococcygeal hiatus), subacromial-deltoid bursa or knee \< 6 months
- Characterized depressive disorder diagnosed recently (for less than 6 months) or not stabilized
- Previous use of a virtual reality headset during treatment
- Being under guardianship or curatorship
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Rheumatology department Hôpital Saint Antoine
Paris, 75012, France
Study Officials
- PRINCIPAL INVESTIGATOR
Alice COURTIES, Medical doctor
APHP
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Target Duration
- 1 Day
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
May 14, 2025
First Posted
August 5, 2025
Study Start
May 28, 2025
Primary Completion
May 1, 2026
Study Completion
May 1, 2026
Last Updated
August 5, 2025
Record last verified: 2025-07
Data Sharing
- IPD Sharing
- Will not share